EE496 Botulinum Toxin Type a for the Treatment of Focal Spasticity in Children with Cerebral Palsy in Thailand: A Cost-Utility Analysis
Prawjaeng, J., Hadnorntun, P., Leelahavarong, P., Ploypetch, T., Chueluecha, C., Jintakul, N., Wathanadilokul, U., Lomaninoparat, R., Srinonprasert, V., Kumthornthip, W.
Published in Value in health (01.12.2023)
Published in Value in health (01.12.2023)
Get full text
Journal Article
EE310 Botulinum Toxin Type a for the Treatment of Patients with Post-Stroke Focal Spasticity in Thailand: A Cost-Utility Analysis
Hadnorntun, P., Prawjaeng, J., Leelahavarong, P., Tanvijit, P., Chueluecha, C., Jintakul, N., Saringcarinkul, T., Srinonprasert, V., Kumthornthip, W.
Published in Value in health (01.12.2023)
Published in Value in health (01.12.2023)
Get full text
Journal Article
Cost-Utility Analysis of Atazanavir/Ritonavir 200/100 Mg Versus Atazanavir/Ritonavir 300/100 Mg in Thai Adults with Virologic Suppression
Taychakhoonavudh, S, Maneesawangwong, N, Bunupuradah, T, Kiertiburanakul, S, Worrathammasorn, T, Hadnorntun, P, Avihingsanon, A, Chetchotisakd, P, Emery, S, Ruxrungtham, K
Published in Value in health (01.11.2016)
Published in Value in health (01.11.2016)
Get full text
Journal Article
PIN27 - Cost-Utility Analysis of Atazanavir/Ritonavir 200/100 Mg Versus Atazanavir/Ritonavir 300/100 Mg in Thai Adults with Virologic Suppression
Taychakhoonavudh, S, Maneesawangwong, N, Bunupuradah, T, Kiertiburanakul, S, Worrathammasorn, T, Hadnorntun, P, Avihingsanon, A, Chetchotisakd, P, Emery, S, Ruxrungtham, K
Published in Value in health (01.11.2016)
Published in Value in health (01.11.2016)
Get full text
Journal Article